ALT5 Sigma Target of Unusually High Options Trading (NASDAQ:ALTS)

ALT5 Sigma Corporation (NASDAQ:ALTS) was the target of unusually large options trading on Thursday. Stock investors purchased 8,298 call options on the stock. Thisrepresentsanincreaseof597% compared to the typical volume of 1,190 call options.

Hedge Funds Weigh In On ALT5 Sigma

Several hedge funds and other institutional investors have recently made changes to their positions in ALTS. Evernest Financial Advisors LLC acquired a new position in shares of ALT5 Sigma during the second quarter worth approximately $87,000. Geode Capital Management LLC boosted its position in shares of ALT5 Sigma by 27.6% during the second quarter. Geode Capital Management LLC now owns 194,813 shares of the company’s stock worth $1,412,000 after buying an additional 42,157 shares during the period. Finally, Jane Street Group LLC acquired a new position in shares of ALT5 Sigma during the second quarter worth approximately $380,000. 6.27% of the stock is currently owned by institutional investors and hedge funds.

ALT5 Sigma Price Performance

Shares of NASDAQ ALTS opened at $7.21 on Friday. The company has a current ratio of 0.88, a quick ratio of 0.83 and a debt-to-equity ratio of 1.45. The stock has a 50 day simple moving average of $7.93 and a 200-day simple moving average of $6.58. ALT5 Sigma has a 12-month low of $1.55 and a 12-month high of $10.95.

About ALT5 Sigma

ALT5 Sigma Corp. is a clinical-stage biopharmaceutical company, which engages in identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of pain and addiction. It operates under the Biotechnology and Recycling segments.